Roivant Sciences (ROIV) PT Raised to $40 at Bernstein SocGen Group
May 21, 2026 8:55 AM
Bernstein SocGen Group analyst William Pickering raised the price target on Roivant Sciences (NASDAQ: ROIV) to $40.00 (from $35.00) while maintaining a Outperform rating.
